Showing results (41-50 of 75) with videos related to
Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|January 25, 2007
Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive ratsYolanda Alvarez, José V Pérez-Girón, Raquel Hernanz, et al.Journal of Pharmaceutical and Biomedical Analysis|December 10, 2019
Advanced nanomedicine characterization by DLS and AF4-UV-MALS: Application to a HIV nanovaccineMarlène Klein, Mathieu Menta, Tamara G Dacoba, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 22, 2019
Versatile protamine nanocapsules to restore miR-145 levels and interfere tumor growth in colorectal cancer cellsSonia Reimondez-Troitiño, José V González-Aramundiz, Juan Ruiz-Bañobre, et al.Frontiers in Immunology|May 5, 2018
Polymeric Nanocapsules for Vaccine Delivery: Influence of the Polymeric Shell on the Interaction With the Immune SystemMercedes Peleteiro, Elena Presas, Jose Vicente González-Aramundiz, et al.Journal of Hypertension|December 20, 2011
Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stressAngela Martín, José V Pérez-Girón, Raquel Hernanz, et al.Hypertension (Dallas, Tex. : 1979)|July 20, 2016
Spironolactone Prevents Endothelial Nitric Oxide Synthase Uncoupling and Vascular Dysfunction Induced by β-Adrenergic Overstimulation: Role of Perivascular Adipose TissueJamaira A Victorio, Stefano P Clerici, Roberto Palacios, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|September 13, 2002
Postnatal maturation in nitric oxide-induced pulmonary artery relaxation involving cyclooxygenase-1 activityFrancisco Pérez-Vizcaíno, José G López-López, Rocío Santiago, et al.Basic & Clinical Pharmacology & Toxicology|March 31, 2025
Role of Inflammatory and Proresolving Mediators in Endothelial DysfunctionAna M Briones, Raquel Hernanz, Ana B García-Redondo, et al.American Journal of Physiology. Heart and Circulatory Physiology|April 15, 2014
Pioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive ratsJose V Pérez-Girón, Roberto Palacios, Angela Martín, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 19, 2016
Rational design of protamine nanocapsules as antigen delivery carriersJosé Vicente González-Aramundiz, Elena Presas, Inmaculada Dalmau-Mena, et al.Pageof 8